Correlation between antimicrobial resistance and virulence in Klebsiella pneumoniae

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 35, Issue 3, 2016, Pages 333-341

  Hennequin, C ^a,b,e   Robin, F ^a,b,c,d,e  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c INSERM   (France)

^d CEMAGREF   (France)

^e Centre National de Référence de la Résistance Aux Antibiotiques   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BETA LACTAM ANTIBIOTIC; CARBAPENEMASE; CEPHALOSPORINASE; EXTENDED SPECTRUM BETA LACTAMASE; OUTER MEMBRANE PROTEIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; BACTERIAL CAPSULE; BACTERIAL VIRULENCE; CORRELATION ANALYSIS; GENOMICS; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEQUENCE ANALYSIS; BACTERIAL GENOME; DRUG EFFECTS; GENE EXPRESSION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HIGH THROUGHPUT SEQUENCING; HUMAN; KLEBSIELLA INFECTIONS; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; PLASMID; VIRULENCE;

ANTI-INFECTIVE AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CEPHALOSPORINASE; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION; GENOME, BACTERIAL; GENOME-WIDE ASSOCIATION STUDY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; PLASMIDS; VIRULENCE;

EID: 84959560174     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-015-2559-7     Document Type: Review

References (73)

1. Podschun R, Ullmann U (1998) Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11:589–603
2. Chang FY, Chou MY (1995) Comparison of pyogenic liver abscesses caused by Klebsiella pneumoniae and non-K. pneumoniae pathogens. J Formos Med Assoc 94:232–237, Taiwan Yi Zhi
3. Shon AS, Bajwa RPS, Russo TA (2013) Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence 4(2):107–118. doi:10.4161/viru.22718
4. Luo Y, Wang Y, Ye L, Yang J (2014) Molecular epidemiology and virulence factors of pyogenic liver abscess causing Klebsiella pneumoniae in China. Clin Microbiol Infect 20:O818–O824. doi:10.1111/1469-0691.12664
5. Bialek-Davenet S, Criscuolo A, Ailloud F, Passet V, Jones L, Delannoy-Vieillard A-S et al (2014) Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups. Emerg Infect Dis 20:1812–1820. doi:10.3201/eid2011.140206
6. Li B, Yi Y, Wang Q, Woo PCY, Tan L, Jing H et al (2012) Analysis of drug resistance determinants in Klebsiella pneumoniae isolates from a tertiary-care hospital in Beijing, China. PLoS One 7:e42280. doi:10.1371/journal.pone.0042280
7. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB et al (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis Off 48(1):1–12. doi:10.1086/595011
8. Yao B, Xiao X, Wang F, Zhou L, Zhang X, Zhang J (2015) Clinical and molecular characteristics of multi-clone carbapenem-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in a tertiary hospital in Beijing, China. Int J Infect Dis 37:107–112. doi:10.1016/j.ijid.2015.06.023
9. Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18:657–686. doi:10.1128/CMR.18.4.657-686.2005
10. Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M et al (2013) Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13:785–796. doi:10.1016/S1473-3099(13)70190-7
11. Chen Y-T, Chang H-Y, Lai Y-C, Pan C-C, Tsai S-F, Peng H-L (2004) Sequencing and analysis of the large virulence plasmid pLVPK of Klebsiella pneumoniae CG43. Gene 337:189–198. doi:10.1016/j.gene.2004.05.008
12. Lin T-L, Lee C-Z, Hsieh P-F, Tsai S-F, Wang J-T (2008) Characterization of integrative and conjugative element ICEKp1-associated genomic heterogeneity in a Klebsiella pneumoniae strain isolated from a primary liver abscess. J Bacteriol 190:515–526. doi:10.1128/JB.01219-07
13. Chou H-C, Lee C-Z, Ma L-C, Fang C-T, Chang S-C, Wang J-T (2004) Isolation of a chromosomal region of Klebsiella pneumoniae associated with allantoin metabolism and liver infection. Infect Immun 72:3783–3792. doi:10.1128/IAI.72.7.3783-3792.2004
14. Holt KE, Wertheim H, Zadoks RN, Baker S, Whitehouse CA, Dance D et al (2015) Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci U S A 112(27):E3574–E3581. doi:10.1073/pnas.1501049112
15. Da Silva GJ, Mendonça N (2012) Association between antimicrobial resistance and virulence in Escherichia coli. Virulence 3:18–28. doi:10.4161/viru.3.1.18382
16. Vogwill T, MacLean RC (2015) The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach. Evol Appl 8:284–295. doi:10.1111/eva.12202
17. Ramirez MS, Traglia GM, Lin DL, Tran T, Tolmasky ME (2014) Plasmid-mediated antibiotic resistance and virulence in gram-negatives: the Klebsiella pneumoniae paradigm. Microbiol Spectr 2:1–15. doi:10.1128/microbiolspec.PLAS-0016-2013
18. Sirot D, Sirot J, Labia R, Morand A, Courvalin P, Darfeuille-Michaud A et al (1987) Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. J Antimicrob Chemother 20:323–334
19. Calbo E, Garau J (2015) The changing epidemiology of hospital outbreaks due to ESBL-producing Klebsiella pneumoniae: the CTX-M-15 type consolidation. Future Microbiol 10:1063–1075. doi:10.2217/fmb.15.22
20. Di Martino P, Bertin Y, Girardeau JP, Livrelli V, Joly B, Darfeuille-Michaud A (1995) Molecular characterization and adhesive properties of CF29K, an adhesin of Klebsiella pneumoniae strains involved in nosocomial infections. Infect Immun 63:4336–4344
21. Darfeuille-Michaud A, Jallat C, Aubel D, Sirot D, Rich C, Sirot J et al (1992) R-plasmid-encoded adhesive factor in Klebsiella pneumoniae strains responsible for human nosocomial infections. Infect Immun 60:44–55
22. Vernet V, Madoulet C, Chippaux C, Philippon A (1992) Incidence of two virulence factors (aerobactin and mucoid phenotype) among 190 clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamase. FEMS Microbiol Lett 75(1):1–5
23. Brisse S, Fevre C, Passet V, Issenhuth-Jeanjean S, Tournebize R, Diancourt L et al (2009) Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One 4:e4982. doi:10.1371/journal.pone.0004982
24. Shin J, Ko KS (2014) Comparative study of genotype and virulence in CTX-M-producing and non-extended-spectrum-β-lactamase-producing Klebsiella pneumoniae isolates. Antimicrob Agents Chemother 58:2463–2467. doi:10.1128/AAC.02499-13
25. Struve C, Roe CC, Stegger M, Stahlhut SG, Hansen DS, Engelthaler DM et al (2015) Mapping the evolution of hypervirulent Klebsiella pneumoniae. MBio 6:e00630. doi:10.1128/mBio.00630-15
26. Di Martino P, Livrelli V, Sirot D, Joly B, Darfeuille-Michaud A (1996) A new fimbrial antigen harbored by CAZ-5/SHV-4-producing Klebsiella pneumoniae strains involved in nosocomial infections. Infect Immun 64:2266–2273
27. Sahly H, Navon-Venezia S, Roesler L, Hay A, Carmeli Y, Podschun R et al (2008) Extended-spectrum beta-lactamase production is associated with an increase in cell invasion and expression of fimbrial adhesins in Klebsiella pneumoniae. Antimicrob Agents Chemother 52:3029–3034. doi:10.1128/AAC.00010-08
28. Livrelli V, De Champs C, Di Martino P, Darfeuille-Michaud A, Forestier C, Joly B (1996) Adhesive properties and antibiotic resistance of Klebsiella, Enterobacter, and Serratia clinical isolates involved in nosocomial infections. J Clin Microbiol 34:1963–1969
29. Sahly H, Aucken H, Benedí VJ, Forestier C, Fussing V, Hansen DS et al (2004) Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 48(9):3477–3482. doi:10.1128/AAC.48.9.3477-3482.2004
30. Robin F, Hennequin C, Gniadkowski M, Beyrouthy R, Empel J, Gibold L et al (2012) Virulence factors and TEM-type β-lactamases produced by two isolates of an epidemic Klebsiella pneumoniae strain. Antimicrob Agents Chemother 56:1101–1104. doi:10.1128/AAC.05079-11
31. El Fertas-Aissani R, Messai Y, Alouache S, Bakour R (2013) Virulence profiles and antibiotic susceptibility patterns of Klebsiella pneumoniae strains isolated from different clinical specimens. Pathol Biol (Paris) 61:209–216. doi:10.1016/j.patbio.2012.10.004
32. Hennequin C, Forestier C (2007) Influence of capsule and extended-spectrum beta-lactamases encoding plasmids upon Klebsiella pneumoniae adhesion. Res Microbiol 158:339–347. doi:10.1016/j.resmic.2007.02.005
33. Hennequin C, Aumeran C, Robin F, Traore O, Forestier C (2012) Antibiotic resistance and plasmid transfer capacity in biofilm formed with a CTX-M-15-producing Klebsiella pneumoniae isolate. J Antimicrob Chemother 67:2123–2130. doi:10.1093/jac/dks169
34. Wand ME, Baker KS, Benthall G, McGregor H, McCowen JWI, Deheer-Graham A et al (2015) Characterization of pre-antibiotic era Klebsiella pneumoniae isolates with respect to antibiotic/disinfectant susceptibility and virulence in Galleria mellonella. Antimicrob Agents Chemother 59:3966–3972. doi:10.1128/AAC.05009-14
35. Sandegren L, Linkevicius M, Lytsy B, Melhus Å, Andersson DI (2012) Transfer of an Escherichia coli ST131 multiresistance cassette has created a Klebsiella pneumoniae-specific plasmid associated with a major nosocomial outbreak. J Antimicrob Chemother 67:74–83. doi:10.1093/jac/dkr405
36. Shin J, Soo KK (2014) Single origin of three plasmids bearing blaCTX-M-15 from different Klebsiella pneumoniae clones. J Antimicrob Chemother 69:969–972. doi:10.1093/jac/dkt464
37. Yu W-L, Lee M-F, Tang H-J, Chang M-C, Chuang Y-C (2015) Low prevalence of rmpA and high tendency of rmpA mutation correspond to low virulence of extended spectrum β-lactamase-producing Klebsiella pneumoniae isolates. Virulence 6:162–172. doi:10.1080/21505594.2015.1016703
38. Philippon A, Arlet G, Jacoby GA (2002) Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother 46:1–11
39. Barnaud G, Arlet G, Verdet C, Gaillot O, Lagrange PH, Philippon A (1998) Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother 42:2352–2358
40. Compain F, Decré D, Fulgencio J-P, Berraho S, Arlet G, Verdet C (2014) Molecular characterization of DHA-1-producing Klebsiella pneumoniae isolates collected during a 4-year period in an intensive care unit. Diagn Microbiol Infect Dis 80:159–161. doi:10.1016/j.diagmicrobio.2014.06.009
41. Hennequin C, Robin F, Cabrolier N, Bonnet R, Forestier C (2012) Characterization of a DHA-1-producing Klebsiella pneumoniae strain involved in an outbreak and role of the AmpR regulator in virulence. Antimicrob Agents Chemother 56:288–294. doi:10.1128/AAC.00164-11
42. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD et al (2001) Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151–1161. doi:10.1128/AAC.45.4.1151-1161.2001
43. Lavigne J-P, Cuzon G, Combescure C, Bourg G, Sotto A, Nordmann P (2013) Virulence of Klebsiella pneumoniae isolates harboring bla KPC-2 carbapenemase gene in a Caenorhabditis elegans model. PLoS One 8:e67847. doi:10.1371/journal.pone.0067847
44. Hammerum AM, Toleman MA, Hansen F, Kristensen B, Lester CH, Walsh TR et al (2010) Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis 10:829–830. doi:10.1016/S1473-3099(10)70276-0
45. Poirel L, Héritier C, Tolün V, Nordmann P (2004) Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 48:15–22
46. Voulgari E, Zarkotou O, Ranellou K, Karageorgopoulos DE, Vrioni G, Mamali V et al (2013) Outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in Greece involving an ST11 clone. J Antimicrob Chemother 68:84–88. doi:10.1093/jac/dks356
47. Siu LK, Lin J-C, Gomez E, Eng R, Chiang T (2012) Virulence and plasmid transferability of KPC Klebsiella pneumoniae at the Veterans Affairs Healthcare System of New Jersey. Microb Drug Resist 18:380–384. doi:10.1089/mdr.2011.0241
48. De Rosa FG, Corcione S, Cavallo R, Di Perri G, Bassetti M (2015) Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda. Future Microbiol 10:283–294. doi:10.2217/fmb.14.121
49. McLaughlin MM, Advincula MR, Malczynski M, Barajas G, Qi C, Scheetz MH (2014) Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonella model and a pilot study to translate to patient outcomes. BMC Infect Dis 14:31. doi:10.1186/1471-2334-14-31
50. Beyrouthy R, Robin F, Dabboussi F, Mallat H, Hamzé M, Bonnet R (2014) Carbapenemase and virulence factors of Enterobacteriaceae in North Lebanon between 2008 and 2012: evolution via endemic spread of OXA-48. J Antimicrob Chemother 69:2699–2705. doi:10.1093/jac/dku181
51. Fuursted K, Schøler L, Hansen F, Dam K, Bojer MS, Hammerum AM et al (2012) Virulence of a Klebsiella pneumoniae strain carrying the New Delhi metallo-beta-lactamase-1 (NDM-1). Microbes Infect 14:155–158. doi:10.1016/j.micinf.2011.08.015
52. Chen J-H, Siu LK, Fung C-P, Lin J-C, Yeh K-M, Chen T-L et al (2010) Contribution of outer membrane protein K36 to antimicrobial resistance and virulence in Klebsiella pneumoniae. J Antimicrob Chemother 65:986–990. doi:10.1093/jac/dkq056
53. Kurupati P, Teh BK, Kumarasinghe G, Poh CL (2006) Identification of vaccine candidate antigens of an ESBL producing Klebsiella pneumoniae clinical strain by immunoproteome analysis. Proteomics 6:836–844. doi:10.1002/pmic.200500214
54. Tsai Y-K, Fung C-P, Lin J-C, Chen J-H, Chang F-Y, Chen T-L et al (2011) Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence. Antimicrob Agents Chemother 55:1485–1493. doi:10.1128/AAC.01275-10
55. Bialek S, Lavigne J-P, Chevalier J, Marcon E, Leflon-Guibout V, Davin A et al (2010) Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model. Antimicrob Agents Chemother 54:4373–4378. doi:10.1128/AAC.01607-09
56. March C, Cano V, Moranta D, Llobet E, Pérez-Gutiérrez C, Tomás JM et al (2013) Role of bacterial surface structures on the interaction of Klebsiella pneumoniae with phagocytes. PLoS One 8:e56847. doi:10.1371/journal.pone.0056847
57. De Champs C, Rich C, Chandezon P, Chanal C, Sirot D, Forestier C (2004) Factors associated with antimicrobial resistance among clinical isolates of Klebsiella pneumoniae: 1-year survey in a French university hospital. Eur J Clin Microbiol Infect Dis 23:456–462. doi:10.1007/s10096-004-1144-2
58. Piddock LJV (2006) Multidrug-resistance efflux pumps—not just for resistance. Nat Rev Microbiol 4:629–636. doi:10.1038/nrmicro1464
59. Padilla E, Llobet E, Doménech-Sánchez A, Martínez-Martínez L, Bengoechea JA, Albertí S (2010) Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrob Agents Chemother 54:177–183. doi:10.1128/AAC.00715-09
60. Veleba M, Higgins PG, Gonzalez G, Seifert H, Schneiders T (2012) Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae. Antimicrob Agents Chemother 56:4450–4458. doi:10.1128/AAC.00456-12
61. Bialek-Davenet S, Lavigne J-P, Guyot K, Mayer N, Tournebize R, Brisse S et al (2015) Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae. J Antimicrob Chemother 70:81–88. doi:10.1093/jac/dku340
62. Ogawa W, Onishi M, Ni R, Tsuchiya T, Kuroda T (2012) Functional study of the novel multidrug efflux pump KexD from Klebsiella pneumoniae. Gene 498(2):177–182. doi:10.1016/j.gene.2012.02.008
63. Coudeyras S, Nakusi L, Charbonnel N, Forestier C (2008) A tripartite efflux pump involved in gastrointestinal colonization by Klebsiella pneumoniae confers a tolerance response to inorganic acid. Infect Immun 76:4633–4641. doi:10.1128/IAI.00356-08
64. Ogawa W, Minato Y, Dodan H, Onishi M, Tsuchiya T, Kuroda T (2015) Characterization of MATE-type multidrug efflux pumps from Klebsiella pneumoniae MGH78578. PLoS One 10:e0121619. doi:10.1371/journal.pone.0121619
65. Mazzariol A, Zuliani J, Cornaglia G, Rossolini GM, Fontana R (2002) AcrAB efflux system: expression and contribution to fluoroquinolone resistance in Klebsiella spp. Antimicrob Agents Chemother 46:3984–3986
66. Liao C-H, Hsueh P-R, Jacoby GA, Hooper DC (2013) Risk factors and clinical characteristics of patients with qnr-positive Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother 68:2907–2914. doi:10.1093/jac/dkt295
67. Tóth A, Kocsis B, Damjanova I, Kristóf K, Jánvári L, Pászti J et al (2014) Fitness cost associated with resistance to fluoroquinolones is diverse across clones of Klebsiella pneumoniae and may select for CTX-M-15 type extended-spectrum β-lactamase. Eur J Clin Microbiol Infect Dis 33:837–843. doi:10.1007/s10096-013-2022-6
68. Ah Y-M, Kim A-J, Lee J-Y (2014) Colistin resistance in Klebsiella pneumoniae. Int J Antimicrob Agents 44:8–15. doi:10.1016/j.ijantimicag.2014.02.016
69. Cannatelli A, D’Andrea MM, Giani T, Di Pilato V, Arena F, Ambretti S et al (2013) In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob Agents Chemother 57:5521–5526. doi:10.1128/AAC.01480-13
70. Wright MS, Suzuki Y, Jones MB, Marshall SH, Rudin SD, van Duin D et al (2015) Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance. Antimicrob Agents Chemother 59:536–543. doi:10.1128/AAC.04037-14
71. Choi M-J, Ko KS (2015) Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains. Antimicrob Agents Chemother 59:6763–6773. doi:10.1128/AAC.00952-15
72. Liu Y-Y, Wang Y, Walsh TR, Yi L-X, Zhang R, Spencer J et al (2015) Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. pii: S1473-3099(15)00424-7. doi:10.1016/S1473-3099(15)00424-7
73. Ramos PIP, Picão RC, de Almeida LGP, Lima NCB, Girardello R, Vivan ACP et al (2014) Comparative analysis of the complete genome of KPC-2-producing Klebsiella pneumoniae Kp13 reveals remarkable genome plasticity and a wide repertoire of virulence and resistance mechanisms. BMC Genomics 15:54. doi:10.1186/1471-2164-15-54